Personalized therapies for the treatment cancer indications
VestCar™ is a CAR-T project that is focused on developing personalized therapies for the
treatment of several cancer indications, including ovarian, pancreatic, lung, prostate,
colorectal, and triple-negative breast cancers. VestCar™ has already made significant
progress in its development, with a patent filed and preclinical studies underway. The company
has also submitted an IND application, with plans to move into clinical trials in the near future.
These milestones represent significant progress for the program and demonstrate the potential
of VestCar™ to be a game-changer in the field of cancer treatment.
VESTCAR01 – Ovarian/Pancreatic/Lung Cancers
VESTCAR02 – Prostate/Colorectal/Triple Negative Breast Cancers